Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
8.01
-0.01 (-0.12%)
At close: Mar 6, 2026, 4:00 PM EST
8.17
+0.16 (2.00%)
After-hours: Mar 6, 2026, 6:39 PM EST
CRBP Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CRBP stock have an average target of 46.17, with a low estimate of 38 and a high estimate of 53. The average target predicts an increase of 476.40% from the current stock price of 8.01.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2025.
Analyst Ratings
The average analyst rating for CRBP stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 3 |
| Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 9 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +561.67% | Nov 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $31 → $38 | Buy | Maintains | $31 → $38 | +374.41% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +399.38% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +399.38% | Sep 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $56 → $53 | Buy | Maintains | $56 → $53 | +561.67% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
1.70M
Revenue Next Year
3.40M
from 1.70M
Increased by 100.00%
EPS This Year
-6.80
from -3.68
EPS Next Year
-5.54
from -6.80
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.5M | 21.0M | ||||
| Avg | 1.7M | 3.4M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 1,135.3% | ||||
| Avg | - | 100.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.72 | -4.10 | ||||
| Avg | -6.80 | -5.54 | ||||
| Low | -12.31 | -7.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.